UMIN ID: UMIN000001452
Registered date:23/10/2008
A clinical trial of R-CHOP with antiretroviral therapy for newly diagnosed CD20 positive AIDS-related non-Hodgkin lymphoma
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Newly diagnosed CD20 positive AIDS-related non-Hodgkin lymphoma |
Date of first enrollment | 2007/09/01 |
Target sample size | 42 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | R-CHOP with HAART |
Outcome(s)
Primary Outcome | The 2-year progression-free survival |
---|---|
Secondary Outcome | The 2-year overall survival, remission rate, toxicity, and the incidence of opportunistic infections |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 70years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1)Burkitt's lymphoma 2)CNS involvement 3)Uncontrolled opportunistic infections |
Related Information
Primary Sponsor | AIDS Clinical Center |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | None |
Secondary ID(s) |
Contact
public contact | |
Name | Junko Tanuma |
Address | Japan |
Telephone | |
jtanuma@acc.ncgm.go.jp | |
Affiliation | National Center for Global Health and Medicine AIDS Clinical Center |
scientific contact | |
Name | Junko Tanuma |
Address | 1-21-1, Toyama, Shinjuku, Tokyo Japan |
Telephone | 03-3202-7181 |
Affiliation | National Center for Global Health and Medicine AIDS Clinical Center |